跳至主要内容
临床试验/IRCT20210213050344N1
IRCT20210213050344N1招募中3 期

Investigation of the Effectiveness of Ivermectin on Outpatient Treatment of Covid-19 Patients, Shiraz City, Southern Iran, 2020: A Randomized Controlled Trial Study (RCT)

Shiraz University of Medical Sciences0 个研究点目标入组 375 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
375

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • Clients to selected outpatient treatment centers in Shiraz
  • Only mild symptoms and clinical manifestations (including: fever less than 38 degrees, sore throat with or without dry cough, chills, headache, loss of taste and smell, nausea, vomiting, anorexia, diarrhea, body aches, weakness and Excessive fatigue, persistent yard symptoms)
  • Positive RT-PCR test result
  • Age between 18 and 80 years
  • People with underlying disease (to evaluate the effectiveness of the drug on people with underlying disease)
  • Individuals who have completed and signed the written consent to participate in the project
  • Blood oxygen level 93% and above (O2 sat = 93%)

排除标准

  • Pregnant mothers
  • Breastfeeding mothers
  • Severe liver disease
  • Severe kidney disease
  • Severe lung disease
  • HIV Positive patients
  • Chronic obstructive pulmonary disease (COPD)
  • Participate in another RCT
  • Dissatisfaction with participating in the study

研究者

相似试验